Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer-Reference-Cited by-同舟云学术

Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer

Published:2005-09 Issue:2 Volume:4 Page:91-99
ISSN:1540-0352
Container-title:Clinical Prostate Cancer
language:en
Short-container-title:Clinical Prostate Cancer

Author:

Hawkins Robert E.,Daigneault Luc,Cowan Richard,Griffiths Richard,Panchal Chandra,Armstrong Anne,Fenemore Jackie,Irvine Alan,Sereda Kasia,Dulude Hélène

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Cancer Statistics, 2005;Jemal;CA Cancer J Clin,2005

2. Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure;Hanks;Int J Radiat Oncol Biol Phys,1994

3. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer;Zincke;J Urol,1994

4. State-of-the-art treatment of metastatic hormone-refractory prostate cancer;Goodin;Oncologist,2002

5. Current strategies in the management of hormone refractory prostate cancer;Martel;Cancer Treat Rev,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers;Cancer Biology & Medicine;2019

2. Drug discovery in advanced prostate cancer: translating biology into therapy;Nature Reviews Drug Discovery;2016-07-22

3. Development and validation of a UHPLC-UV method for the determination of a prostate secretory protein 94-derived synthetic peptide (PCK3145) in human plasma and assessment of its stability in human plasma;Biomedical Chromatography;2016-03-21

4. PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer;Oncogene;2013-11-04

5. MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases;The Prostate;2013-09-30